Screener
Eligibility screening
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) na…
3 US sites in FL, PA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.